SLI
|
1 813,97
|
-0,94
|
-0,05%
|
Analysen zu SLI-Werten
| 03.04.25 | Novartis Outperform | Bernstein Research | |
| 03.04.25 | Roche Outperform | Bernstein Research | |
| 03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.04.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 01.04.25 | Richemont Sector Perform | RBC Capital Markets | |
| 31.03.25 | Zurich Insurance Sell | UBS AG | |
| 31.03.25 | Swiss Re Buy | UBS AG | |
| 28.03.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 28.03.25 | Richemont Outperform | Bernstein Research | |
| 28.03.25 | Richemont Buy | UBS AG | |
| 28.03.25 | Richemont Sector Perform | RBC Capital Markets | |
| 27.03.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 27.03.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | ABB Sell | Deutsche Bank AG | |
| 26.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.03.25 | ABB Hold | Jefferies & Company Inc. | |
| 25.03.25 | Nestlé Neutral | UBS AG | |
| 25.03.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 25.03.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 24.03.25 | Richemont Outperform | Bernstein Research | |
| 24.03.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 24.03.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 21.03.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 20.03.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 19.03.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 19.03.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.03.25 | UBS Outperform | RBC Capital Markets | |
| 17.03.25 | UBS Outperform | RBC Capital Markets | |
| 17.03.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 14.03.25 | Givaudan Add | Baader Bank | |
| 14.03.25 | Givaudan Hold | Deutsche Bank AG | |
| 14.03.25 | Givaudan Neutral | UBS AG | |
| 14.03.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.03.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 13.03.25 | Swiss Re Buy | UBS AG | |
| 13.03.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 13.03.25 | Roche Hold | Jefferies & Company Inc. | |
| 12.03.25 | Roche Outperform | Bernstein Research | |
| 12.03.25 | Roche Buy | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.